At the heart of this study is the concept of the exposome—the comprehensive total of environmental exposures that an individual encounters from conception onward. While previous research has typically isolated single environmental factors, this new investigation takes a holistic approach, examining the interplay of 91 different exposures clustered into thirteen distinct families. These categories range from outdoor air pollutants and proximity to green and blue natural spaces, to indoor chemical agents, household air quality, lifestyle elements like diet and tobacco exposure, and complex socioeconomic indicators including parental education and community support networks.

Central to the research is the immune system’s response during critical windows of early development, a period when regulation of inflammation has far-reaching implications for a child’s cardiometabolic, respiratory, and neurodevelopmental health. Chronic inflammation is a well-recognized pathway in the etiology of major health burdens such as obesity, diabetes, asthma, and neurodevelopmental disorders. Understanding how the exposome influences immune system programming could pave the way for innovative prevention strategies targeting inflammation at its roots.

The HELIX cohort, encompassing 845 children from six European countries including the United Kingdom, France, Spain, Lithuania, Norway, and Greece, provided a rich, population-based dataset. This geographically diverse sample allowed researchers to capture a wide spectrum of environmental variability. Notably, pre- and postnatal exposures were meticulously assessed, affording insights into how the intrauterine and early childhood environments collectively shape immune ontogeny.

To dissect the complex interactions between exposures and immune function, the researchers employed a multi-omics approach combining three biological layers from blood samples: white blood cell composition, plasma protein concentrations related to immune signaling, and genome-wide DNA methylation patterns of white blood cells. This triad offered a powerful lens through which to monitor immune signatures, encompassing both the cellular components and epigenetic influences that govern inflammation and immune regulation.

The data analysis involved sophisticated statistical modeling, notably Regularized Generalized Canonical Correlation Analysis (RGCCA), an advanced algorithm adept at integrating high-dimensional multi-omics and exposome datasets. By aligning immune system profiles with composite health scores—incorporating respiratory function, metabolic health, and cognitive outcomes—the team delineated immune “signatures” that correlate with better overall health trajectories in children.

Most notably, the study identified three distinct immune profiles that were robustly associated with improved health outcomes. Two of these signatures, characterized by reduced levels of inflammatory plasma proteins, suggest a systemic attenuation of low-grade chronic inflammation. The third immune pattern reflected a more equilibrated white blood cell profile, indicative of finely tuned immune regulation rather than immune hyperactivation or dysregulation.

What distinguishes this research is its elucidation of specific environmental determinants linked to these favorable immune signatures. Better indoor air quality emerged as a pivotal factor—a finding particularly relevant given children’s prolonged exposure to indoor environments. Proximity to blue spaces, such as lakes, rivers, and coastal areas, was also strongly associated with healthier immune profiles, underscoring the salutogenic effects of natural water bodies on physiological stress reduction and immune modulation.

Dietary patterns exhibiting higher nutritional quality and adherence to healthy eating guidelines correlated with the beneficial immune patterns, reinforcing the role of nutrition in immune development. Furthermore, higher levels of social capital—encompassing family cohesion, community engagement, and social support networks—were linked to the regulation of immune function. These social determinants likely buffer stress and modulate neuroimmune pathways, contributing to reduced inflammatory activation.

The implications of these findings are profound. They highlight modifiable environmental factors that can be targeted through public health policies and community interventions to foster healthier immune development in children, potentially curbing the rise of chronic diseases rooted in childhood inflammation. The researchers advocate for integrated strategies focusing on indoor environmental improvements, preservation of natural spaces, promotion of nutritious diets, and bolstering of social support systems.

Lead author Ines Amine emphasized the complexity and novelty of integrating multi-omics immunological data with a broad spectrum of environmental exposures during early life. This systems biology approach uncovers mechanisms underlying the exposome’s influence on immunity, providing a blueprint for future research and policy action. Co-author Léa Maitre, coordinator of the Exposome Hub at ISGlobal, articulated the clinical significance of mitigating immunotoxicity through environmental interventions, especially given the rising public health burden of non-communicable diseases with inflammatory etiologies.

This study represents a landmark step in exposome research, situating immune regulation as a critical nexus between environment and health. It further exemplifies the power of collaborative international research consortia and cutting-edge data analytics in unraveling the complex determinants of pediatric health. The insights garnered herald new avenues for personalized and population-level preventive strategies, emphasizing the environment as a pivotal player in lifelong health trajectories.

In conclusion, by elucidating how quality of indoor air, closeness to natural spaces, dietary habits, and social fabric collectively influence immune development and inflammation regulation, this investigation calls for transformative investments in holistic environmental and social infrastructures. Such integrative approaches hold promise for diminishing the burden of chronic inflammatory diseases from childhood onward, ultimately fostering resilient and healthier future generations.

Subject of Research: People

Article Title: Early-life exposome and health-related immune signatures in childhood

References:
Amine, I., Anguita-Ruiz, A., Guillien, A., Basagaña, X., Bustamante, M., Borràs, E., Cirach, M., Dedele, A., Dobaño, C., Garcia-Aymerich, J., Granum, B., Grazuleviciene, R., González, J. R., Julvez, J., Keun, H., López-Vicente, M., McEachan, R., Moncunill, G., Nieuwenhuijsen, M., … Maitre, L. (2025). Early-life exposome and health-related immune signatures in childhood. Environment International, 202(109668), 109668. DOI: 10.1016/j.envint.2025.109668

Keywords:
Epigenetics, Immune system, Child welfare, Children

The investigation began with the isolation and profiling of four distinct B-1 developmental stages: fetal liver B-1 progenitors, adult bone marrow B-1 progenitors, peritoneal cavity B-1 cells, and splenic B-1 cells. By applying trajectory analysis to this comprehensive dataset, researchers discerned a continuous developmental path beginning with fetal liver progenitors and culminating in mature peripheral B-1 cells. Notably, splenic and peritoneal B-1 cells clustered near the mature end of the trajectory, highlighting their advanced differentiation state.

Importantly, a small subset of splenic and peritoneal cavity B-1 cells localized within the fetal liver progenitor cluster, providing compelling evidence for the existence of splenic B-1a precursors. This finding challenges previous paradigms that predominantly situated B-1 progenitors within hepatic or bone marrow niches, underscoring the dynamic nature of B-1a cell ontogeny.

Expression analyses revealed contrasting patterns for Lef1 and Tcf7 (encoding LEF1 and TCF1, respectively). Lef1 was robustly expressed in B-1 progenitors derived from both fetal liver and bone marrow, with expression levels waning in peripheral mature B-1 cells. Conversely, Tcf7 expression was minimal in progenitor populations but escalated significantly in splenic and peritoneal cavity B-1 cells. This reciprocal expression suggests temporally distinct roles for these transcription factors during B-1 cell development.

Further characterization of gene expression patterns elucidated molecules intimately associated with B-1 cell ontogeny. Fetal B-1 progenitors prominently expressed Lin28b, Arid3a, and Il7r, genes previously implicated in lymphoid development and progenitor maintenance. Bone marrow progenitors exhibited elevated Bhlhe41 expression, which intensified in mature splenic and peritoneal B-1 cell populations. Mature B-1 cells also uniquely expressed Ctla4 and Bmi1, genes linked to immune regulation and cellular longevity.

Functional interrogation of signaling pathways illuminated distinct consequences of LEF1 and TCF1 deficiencies. Loss of LEF1 perturbed the IL-6–STAT3, TGFβ, and TNF signaling cascades, pathways integral to inflammation and cellular communication. In contrast, TCF1 deficiency principally disrupted cell cycle processes, notably the regulation of E2F targets and G2–M phase checkpoints, indicating a pivotal role for TCF1 in controlling B-1 cell proliferation. Strikingly, deficiencies in either transcription factor converged on dysregulation of the IL-2–STAT5 signaling pathway, underscoring IL-2 signaling as a shared and essential axis for B-1a cell function.

Reanalysis of a comprehensive human prenatal single-cell atlas revealed parallel expression patterns. Cells expressing classical mouse B-1a markers such as CD5 and SPN (encoding CD43) consistently co-expressed TCF1 and LEF1. Those co-expressing both transcription factors exhibited heightened expression of CD5, SPN, IL2RG, and IL7RA compared to cells expressing either factor alone. This conserved signature implicates TCF1 and LEF1 as crucial regulators not only in mouse but also in human B-1 cell biology.

Intriguingly, human progenitor B cells, including the ProB subset known for proliferative capacity, also expressed TCF1 and LEF1, mirroring observations in mice. This was corroborated by MKI67 expression, a well-established marker of cellular proliferation, which appeared prominently in cycling B cells co-expressing these transcription factors. Such findings align with the concept that TCF1 and LEF1 orchestrate developmental and proliferative programs in early B-lineage cells.

Given the centrality of IL-2 signaling downstream of TCF1 and LEF1, the research investigated B-1-like populations in human patients with severe combined immunodeficiency (SCID) attributed to mutations in IL2RG (IL-2 receptor gamma chain) and IL7RA (IL-7 receptor alpha chain). Remarkably, pediatric patients harboring IL-2Rγ deficiency exhibited an approximate 80% reduction in circulating B-1-like cells compared to healthy controls. This stark reduction underscores the indispensable nature of IL-2Rγ-mediated signaling for human B-1 cell maintenance.

Nonetheless, the authors caution that age disparities between patients (median 6 years) and healthy donors (median 24 years), coupled with evidence that adult mice possess twice as many B-1a cells as their juvenile counterparts, warrant further investigation before definitive causal relationships can be established in humans. Such nuances exemplify the complexity underlying immunological development and phenotypic variation.

This study’s revelations advance our understanding of B-1a cell biology by assigning precise molecular functions to TCF1 and LEF1, illuminating previously uncharted territory in immune regulation. The elucidation of signaling pathways, transcriptional circuits, and developmental trajectories marks a significant leap toward therapeutic manipulation of B-1 cells, which are implicated in immunity against pathogens and in autoimmunity.

Future research avenues may explore how modulation of TCF1 and LEF1 activity influences B-1 cell responses during infections and autoimmune conditions. Additionally, given the parallels between mouse and human systems, therapeutic targeting of IL-2 and IL-7 receptor pathways may hold promise for correcting B-1 cell deficiencies in immunodeficiencies or harnessing their regulatory properties.

In sum, this comprehensive work elegantly integrates developmental immunology, molecular genetics, and single-cell transcriptomics to reveal a finely tuned regulatory network governing B-1a cell homeostasis. The cross-species conservation of these mechanisms highlights the evolutionary significance of TCF1 and LEF1 and their potential as key nodes in immune modulation strategies.

Subject of Research: Roles of transcription factors TCF1 and LEF1 in B-1a cell development, homeostasis, and signaling pathways.

Article Title: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function.

Article References:
Shen, Q., Wang, H., Roco, J.A. et al. TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function. Nature (2025). https://doi.org/10.1038/s41586-025-09421-0

Image Credits: AI Generated